Euglycemic DKA on SGLT2 Inhibitors: How to Recognize and Treat This Hidden Emergency

Imagine this: a patient with type 2 diabetes feels nauseous, tired, and has stomach pain. Their blood sugar is 180 mg/dL - not high enough to raise alarms. They’re told it’s just a stomach bug. Two days later, they collapse. This isn’t rare. It’s euglycemic diabetic ketoacidosis - a dangerous form of DKA that hides in plain sight because blood sugar stays normal. And it’s rising because of a class of diabetes drugs called SGLT2 inhibitors.

What Is Euglycemic DKA, and Why Does It Happen?

Euglycemic diabetic ketoacidosis (EDKA) is diabetic ketoacidosis without the high blood sugar you’d expect. Classic DKA happens when insulin drops, the body burns fat for fuel, and ketones flood the bloodstream - along with blood glucose over 250 mg/dL. EDKA looks the same: acidosis, ketones, nausea, rapid breathing - but glucose stays below 250 mg/dL. That’s the trap.

It’s tied to SGLT2 inhibitors like dapagliflozin (Farxiga), empagliflozin (Jardiance), and canagliflozin (Invokana). These drugs work by making your kidneys dump glucose into urine. That lowers blood sugar - great for control. But it also tricks your body into thinking it’s starving. Your pancreas releases more glucagon, less insulin. Fat breaks down. Ketones rise. And because glucose is being flushed out, your blood sugar doesn’t spike. You get ketoacidosis without the warning sign.

This isn’t just theory. A 2015 study in Diabetes Care found 13 cases of EDKA linked to SGLT2 inhibitors in just nine patients. The FDA issued a warning that same year. Since then, data shows SGLT2 inhibitor users have a 7-fold higher risk of DKA than non-users. Even more alarming: 20% of EDKA cases happen in people with type 2 diabetes who’ve never had DKA before.

Who’s at Risk?

Not everyone on these drugs gets EDKA. But certain situations make it far more likely:

• Illness - colds, flu, infections
• Reduced food intake - skipping meals, fasting, dieting
• Surgery or trauma
• Pregnancy
• Alcohol use
• Insulin dose reduction (especially in type 1 diabetes)

And here’s the twist: even though SGLT2 inhibitors aren’t approved for type 1 diabetes, about 8% of those patients take them off-label. In this group, DKA rates jump to 5-12%. Many of these cases are euglycemic. That’s why emergency teams now treat anyone on an SGLT2 inhibitor with nausea or vomiting as potentially in EDKA - no matter what their glucose reads.

How to Spot It - The Symptoms Are the Same

EDKA doesn’t have unique symptoms. It mimics every other common illness:

• Nausea (85% of cases)
• Vomiting (78%)
• Abdominal pain (65%)
• Unusual fatigue (76%)
• Malaise (91%)
• Deep, fast breathing (Kussmaul respirations - 62%)

You might expect a fruity breath smell - like acetone - but that’s not reliable. Ketone levels can be lower in EDKA, so the odor fades. Blood glucose is normal. No red flags. That’s why so many patients are misdiagnosed with gastroenteritis, food poisoning, or even appendicitis.

Lab Tests That Reveal the Truth

If you suspect EDKA, don’t wait for high glucose. Test for ketones - and test them right.

• Blood beta-hydroxybutyrate: The gold standard. Levels above 3 mmol/L confirm ketoacidosis.
• Arterial blood gas: pH below 7.3, bicarbonate under 18 mEq/L = metabolic acidosis.
• Anion gap: Usually over 12 mEq/L.
• Serum glucose: Below 250 mg/dL - this is the red herring.
• Electrolytes: Potassium may look normal, but total body potassium is often dangerously low.

A 2023 study found that the ratio of acetoacetate to beta-hydroxybutyrate rises before symptoms appear. That could become a future early warning sign. But for now, if you’re on an SGLT2 inhibitor and feel off - check ketones. Use a blood ketone meter if you can. Urine strips are less accurate and can miss early ketosis.

Emergency Treatment - It’s Different From Regular DKA

Treatment follows the same principles as classic DKA: fluids, insulin, electrolytes. But EDKA needs adjustments.

• Fluids: Start with 0.9% saline at 15-20 mL/kg in the first hour. Dehydration is real. But don’t overdo it - you’re not dealing with severe hyperglycemia.
• Insulin: Begin at 0.1 units/kg/hour. But here’s the key: once glucose drops below 200 mg/dL, switch to 5% dextrose in saline. You can’t let glucose crash. The body’s already low on fuel.
• Potassium: Almost everyone needs replacement. Even if serum potassium is normal, total body stores are depleted. Start IV potassium early.
• Monitor closely: Check glucose every hour. Ketones every 2-4 hours. Electrolytes every 4-6 hours.

The Cleveland Clinic’s emergency protocol requires serum ketone testing within 15 minutes of triage for any diabetic on an SGLT2 inhibitor with nausea or vomiting. Results must be ready in 30 minutes. That’s how serious this is.

Prevention Is the Best Strategy

The FDA now requires SGLT2 inhibitor packaging to include this warning: "Stop taking this medication and seek medical help immediately if you have symptoms of ketoacidosis, even if your blood sugar is normal."

Patients need clear instructions:

• Stop your SGLT2 inhibitor during illness, surgery, or fasting.
• Check ketones if you feel unwell - even if your glucose is 150 or 200.
• Don’t skip meals. Eat carbohydrates even if you’re sick.
• Keep a blood ketone meter at home if you’re high-risk.
• Tell every doctor you see that you’re on an SGLT2 inhibitor.

Doctors should avoid starting SGLT2 inhibitors in patients with a history of DKA. For type 1 diabetes patients, use them only if absolutely necessary - and monitor ketones closely.

Why This Matters Now

As of 2023, SGLT2 inhibitors make up 25% of all new diabetes prescriptions in the U.S. Dapagliflozin and empagliflozin are the most common. These drugs reduce heart failure and kidney disease - huge wins. But EDKA kills. And it kills quietly.

Since 2015, awareness has cut overall DKA cases by 32%. But EDKA now makes up 41% of all SGLT2-related DKA - up from 28%. That means we’re getting better at spotting it, but the risk hasn’t gone away. It’s just more hidden.

Research is moving fast. A study at 15 U.S. centers is testing a tool that predicts EDKA risk using HbA1c variability and C-peptide levels. Early results show 82% accuracy. That could one day tell you if you’re in danger before you even feel sick.

But right now, the only tool that saves lives is knowledge. If you’re on an SGLT2 inhibitor, you must know: normal glucose does not mean safe. Ketones don’t care about your blood sugar number. They care about insulin, glucagon, and fuel.

Frequently Asked Questions